The present studies show that the previously reported ability of fetuin to inhibit the precipitation of hydroxyapatite from supersaturated solutions of calcium and phosphate in vitro is accompanied by the formation of the fetuin-mineral complex (FMC), a high molecular weight complex of calcium phosphate mineral and the proteins fetuin and matrix Gla protein that was initially discovered in serum of rats treated with etidronate and appears to play a critical role in inhibiting calcification in vivo. Rat serum potently inhibited the precipitation of calcium phosphate mineral when the concentration of calcium and phosphate were increased by 10mM each and the modified serum was incubated at 37Û&IRUGD\VLQWKHDEVHQFHRIVHUXP precipitation occurred in seconds. Large amounts of the FMC were generated in the first 3h of this incubation, and remained throughout the 9d incubation. Purified bovine fetuin inhibited the precipitation of mineral for over 14d in a solution containing 5mM calcium and phosphate at pH 7.4 at 22Û&ZKLOHSUHFLSLWDWLRQRFFXUUHGLQPLQXWHVZLWKRXWIHWXLQ7KHUHZDVDELSKDVLFGURSLQ ionic calcium in the fetuin solution, however, from 5 to 3mM in the first hour and from 3 to 0.9mM between 20 and 24h; these changes in ionic calcium are due to the formation of complexes of calcium, phosphate, and fetuin. The complex found at 24h to 14d is identical to the FMC found in the serum of etidronate-treated rats, while the complex found between 1 and 20h is less stable. 
SUMMARY
The present studies show that the previously reported ability of fetuin to inhibit the precipitation of hydroxyapatite from supersaturated solutions of calcium and phosphate in vitro is accompanied by the formation of the fetuin-mineral complex (FMC), a high molecular weight complex of calcium phosphate mineral and the proteins fetuin and matrix Gla protein that was initially discovered in serum of rats treated with etidronate and appears to play a critical role in inhibiting calcification in vivo. Rat serum potently inhibited the precipitation of calcium phosphate mineral when the concentration of calcium and phosphate were increased by 10mM each and the modified serum was incubated at 37Û&IRUGD\VLQWKHDEVHQFHRIVHUXP precipitation occurred in seconds. Large amounts of the FMC were generated in the first 3h of this incubation, and remained throughout the 9d incubation. Purified bovine fetuin inhibited the precipitation of mineral for over 14d in a solution containing 5mM calcium and phosphate at pH 7.4 at 22Û&ZKLOHSUHFLSLWDWLRQRFFXUUHGLQPLQXWHVZLWKRXWIHWXLQ7KHUHZDVDELSKDVLFGURSLQ ionic calcium in the fetuin solution, however, from 5 to 3mM in the first hour and from 3 to 0.9mM between 20 and 24h; these changes in ionic calcium are due to the formation of complexes of calcium, phosphate, and fetuin. The complex found at 24h to 14d is identical to the FMC found in the serum of etidronate-treated rats, while the complex found between 1 and 20h is less stable.
INTRODUCTION
The present studies were carried out in order to better understand the mechanisms responsible for the generation of the serum fetuin-mineral complex in the rat. The fetuin-mineral complex is a complex of a calcium phosphate mineral phase and the proteins fetuin and matrix Gla protein (MGP 1 ) that appears in the blood of rats treated with doses of etidronate that acutely inhibit bone mineralization (1) . The appearance of this complex in serum following etidronate injection causes a 4-fold increase in total serum calcium without any increase in ionic calcium levels. The fetuin mineral complex is quite stable in serum at 37°C, with no evidence for the growth, aggregation, and precipitation of the mineral component of the complex, which suggests that the previously reported calcification inhibitory 2 activities of fetuin (2, 3) and MGP (4-7) may be related to their ability to form stable complexes with nascent mineral nuclei.
The dominant protein component of the fetuin mineral complex, fetuin, is a 59kDa glycoprotein that consists of 2 N-terminal cystatin domains and a smaller C-terminal domain.
Fetuin is synthesized in the liver and is found at high concentrations in mammalian serum (8, 9) and bone (10) (11) (12) (13) (14) (15) . The serum fetuin concentration in adult mammals ranges from 0.5 to 1.5 mg/ml, while the serum fetuin concentration in the fetus and neonate is typically far higher (9) .
Fetuin is one of the most abundant non-collagenous proteins found in bone (10) (11) (12) (13) (14) (15) , with a concentration of about 1mg fetuin per g bone in rat (14) , bovine (10) , and human (12) bone. In spite of the abundance of fetuin in bone, however, it has not been possible to demonstrate the synthesis of fetuin in calcified tissues, and it is therefore presently thought that the fetuin found in bone arises from hepatic synthesis via serum (13, 15) .
Our working hypothesis is that the serum fetuin-mineral complex is formed spontaneously in bone metabolism under conditions in which fetuin inhibits the spontaneous precipitation of a calcium phosphate mineral phase (16) . Two experimental systems have been used to test this hypothesis. Previous studies have shown that fetuin is the major inhibitor of the precipitation of calcium phosphate mineral found in blood (2) , and the first test accordingly examined the possible generation of the fetuin-mineral complex in serum to which sufficient calcium and phosphate had been added to exceed the spontaneous precipitation of a calcium phosphate mineral phase in serum. Purified bovine fetuin has also been shown to inhibit the precipitation of a calcium phosphate mineral phase from solutions containing supersaturating amounts of calcium and phosphate (2) , and the second test therefore examined the possible generation of the fetuin-mineral complex in the course of this inhibition. The results of these experiments show that a fetuin-mineral complex apparently identical to that found in serum following etidronate administration is indeed generated during the course of the inhibition of calcium phosphate precipitation in serum containing supersaturating amounts of calcium and phosphate, and during the course of inhibition of calcium phosphate precipitation from supersaturated solutions containing purified bovine fetuin.
EXPERIMENTAL PROCEDURES
Materials. Simonsen albino male rats (Sprague-Dawley derived) were purchased from Simonsen Labs (Gilroy, CA). Sephacryl S-300 HR gel filtration media was purchased from Pharmacia (Piscataway, NJ). 45 Ca was purchased from Perkin Elmer Life Sciences (Boston, MA). Microcon YM-10 and Ultrafree CL filtration units were purchased from Millipore. Bovine fetuin (Sigma) was further purified before use by gel filtration over a 2 X 140cm column of Sepharcryl S-300 HR equilibrated with 5mM ammonium bicarbonate.
Formation of the fetuin-mineral complex in rat serum. Blood was obtained from forty-two-day-old male Sprague Dawley rats. Blood was allowed to clot for 30min at room temperature and serum was collected by centrifugation at 1,400 x g for 10 minutes in a clinical centrifuge and was stored in 1ml aliquots at -70ºC until use. To increase the concentrations of calcium and phosphate in serum, an aliquot of 0.5 M CaCl 2 containing 700,000 cpm of 45 Ca label was added rapidly to a 1ml serum aliquot to achieve twice the desired final level of added calcium, and an aliquot of 0.5M sodium phosphate pH 7.4 was added rapidly to a second 1ml serum aliquot to achieve twice the desired final level of added phosphate. The calcium-boosted serum aliquot was then drawn up in a disposable pipet and expelled rapidly into the phosphateboosted aliquot. Serum samples were placed in 35 mm culture dishes (Falcon 3001), and incubated for 3h or 9d in a humidified incubator at 37Û&DQG&2 2. Serum maintained a stable pH value of 7.4 throughout the duration of the incubation.
Formation of the fetuin-mineral complex during the inhibition of calcium phosphate mineral formation by pure fetuin. The formation of calcium phosphate mineral was investigated at room temperature in solutions containing 0.2M HEPES buffer at pH 7.4. In some experiments, 5mg/ml of bovine fetuin was also added to this buffer. In a typical experiment, equal volumes of buffer were first prepared that contained either 10mM phosphate (pH=7.4) or 10mM calcium containing 45 Ca label. These solutions were then mixed rapidly in order to obtain
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withdrawn at the appropriate time after mixing and centrifuged for 10 sec in an epifuge. The supernatants were immediately diluted 1:4 with HEPES buffer in order to arrest further mineral formation and stored at -70ºC until analysis.
Biochemical analyses. Calcium levels were determined colorimetrically using cresolphthalein complexone (Sigma) and phosphate levels were determined colorimetrically as described (17) . Ionic calcium levels were measured at the indicated times using a calciumspecific electrode. Filtration experiments were carried out using 0.5ml aliquots with a Microcon YM-10 filtration unit and using 2ml aliquots with an Ultrafree CL filtration unit. The concentration of rat MGP was determined by radioimmunoassay, as described (18) .
The amount of the high molecular weight fetuin mineral complex in samples was determined by gel filtration using 25ml columns of Sephacryl S-300 HR equilibrated with 20 mM HEPES pH 7.4, 0.15 M NaCl and 10 mM CaCl 2 at room temperature as described previously (1) centrifuged for 30min at 16,000 X g; the resulting pellet was then analyzed as described above.
RESULTS
Formation of the fetuin-mineral complex in serum following the elevation of calcium and phosphate levels. The first experiments were carried out to determine whether the fetuinmineral complex is formed spontaneously when the calcium and phosphate levels in rat serum are increased above normal and the modified serum is then incubated at 37ºC. The possible presence of the fetuin-mineral complex was initially assessed by gel filtration over Sephacryl S300HR, a method that has been shown previously to separate the high molecular weight fetuinmineral complex from most other proteins in serum (1, 16) . Calcium and phosphate were added to serum to increase total levels of each by 10mM and the resulting modified serum was incubated at 37ºC for 3h, a time comparable to that required for the generation of the fetuinmineral complex in vivo (1) . As seen in Figure 1 , Sephacryl S300 analysis of this incubated serum sample revealed the presence of a large peak of calcium and phosphate in the high molecular weight position expected for the fetuin-mineral complex. Additional Sephacryl S300 experiments showed that no detectable high molecular weight peak of calcium and phosphate was formed after incubation for 3h at 37ºC of serum alone or of serum with added 1mM, 2mM, or 5mM calcium and phosphate (data not shown).
The presence of the fetuin-mineral complex in serum was also assessed by centrifugation for 2h at 16,000 X g, a procedure shown previously to sediment the fetuin-mineral complex found in the serum of etidronate-treated rats (1). Calcium and phosphate were again added to increase total serum levels of each by 10mM and the resulting modified serum was incubated at 37ºC for 3h. Centrifugation of this modified serum produced a translucent, compact pellet that was visually identical to the translucent fetuin-mineral complex pellet formed by centrifuging serum from etidronate-treated rats (1) . Chemical analysis of this pellet showed that it contained calcium, phosphate, and MGP (Figure 2A) , and SDS gel electrophoresis of this pellet revealed a protein composition essentially identical to that found in the fetuin-mineral complex pellet formed by centrifugation of serum from an etidronate treated rat (1), with a major band at 59kDa
and a minor band at 66kDa ( Figure 2B , lane 2). N-terminal protein sequencing demonstrated that the 59kDa band is rat fetuin and the 66kDa band is rat albumin
Since albumin is the major protein found in rat serum, with an abundance about 100 fold greater than fetuin, it is possible that the presence of albumin in the pellet fraction could reflect a small contamination of serum within the pellet rather than the specific association of albumin with the fetuin mineral complex. To test this hypothesis, the initial pellet was re-suspended in HEPES buffer and re-pelleted by centrifugation. This stratagem removed essentially all of the albumin contaminant with good recovery of fetuin ( Figure 2B , lane 5), which shows that the presence of albumin in the pellet is probably due to contamination of the pellet with serum rather than to the specific association of albumin with the fetuin-mineral complex.
To further test the ability of serum fetuin to prevent the growth and precipitation of the mineral component of the complex, the levels of calcium and phosphate in rat serum were again increased by 10mM each and the resulting modified serum was incubated for 9 days at 37ºC.
Centrifugation of this modified serum sample showed that a translucent pellet was formed which contained calcium and phosphate in amounts somewhat greater than the amounts seen after 3h incubation, and MGP levels that were significantly lower (Figure 2A ). SDS gel electrophoresis of this pellet revealed a protein composition that is essentially identical to that found for the pellet formed after 3h incubation of the modified serum sample ( Figure 2B , lane 7), with a major band at the 59kDa position of fetuin and a minor band at the 66kDa position of albumin.
These results show that the fetuin-mineral complex formed by incubation of modified serum in vitro is exceptionally stable, and further support the hypothesis that one function of the fetuin component of this complex is to arrest growth of the mineral component.
Formation of the fetuin-mineral complex during the inhibition of calcium phosphate
mineral formation by pure fetuin at 5mM calcium and phosphate. Previous studies have
shown that bovine fetuin is a potent inhibitor of calcium phosphate mineral precipitation (2) , and experiments were accordingly carried out to determine whether the fetuin-mineral complex might be formed in the course of this inhibition. The first experiment monitored the detailed time course of the precipitation of calcium phosphate mineral in the presence and absence of bovine fetuin using 5mM calcium and phosphate at pH 7.4, which are conditions that are essentially identical to those used in previous inhibition studies with bone Gla protein (19) and fetuin (2) . As can be seen in Figure 3 , in the absence of fetuin the precipitation of a calcium phosphate mineral phase is rapid and biphasic, with an initial drop in solution calcium to approximately 3mM within 1 minute, a plateau until 30 minutes, and a subsequent rapid decline to about 0.5mM by 1 hour. The biphasic nature of calcium phosphate precipitation was not noted in earlier studies because the first time points measured were 1h or later (2, 19) . In agreement with the earlier fetuin study (2) , fetuin completely prevented the precipitation of a calcium phosphate mineral phase (Figure 3 ) and the solution remained clear over the 3h period of observation.
To see if the ability of fetuin to prevent the formation of a calcium phosphate precipitate is due to the formation of complexes between fetuin and nascent crystal nuclei, the level of ionic calcium was measured with an ion-specific electrode over the period in which fetuin inhibits the precipitation of a calcium phosphate mineral phase. As can be seen in Figure 4 , ionic calcium levels fell to about 3mM within 1h and then remained at this value for 20h. There was then a transition to 0.9mM calcium at 24h and a slower decrease to less than 0.5mM calcium at 48h.
The biphasic nature of these changes closely parallels the biphasic precipitation of calcium in the absence of fetuin shown in Figure 3 , and the concentration of calcium in the first and second plateau regions is similar. The solution of fetuin and 5mM calcium and phosphate remained completely clear over the initial 16h period of observation. It then became distinctly opalescent by 24h and remained comparably opalescent over a 14-day period of observation, with no evidence for the precipitation of a calcium phosphate mineral phase.
This experiment was repeated using a filtration procedure to separate free calcium from calcium associated with higher molecular weight complexes. As seen in Figure 5 , filtration of the solution of fetuin and 5mM calcium and phosphate through a membrane with a 10 kDa molecular weight cut off revealed a biphasic decrease in filtrate calcium essentially identical to that seen for ionic calcium, with a decrease to 3mM calcium within 1h, a plateau until 16h, and then a decline to below 1mM by 24h. The solution was clear until 16h and again became distinctly opalescent by 24h.
This filtration procedure was repeated in order to obtain quantitative data for the calcium and phosphate content of the solution retained by the filter and the solution that passed through the filter. As seen in Table 1 , a substantial amount of calcium and phosphate was retained during the filtration of the solution obtained at 2h following mixing and the molar ratio of calcium to phosphate in the retained fraction was 1.67. Control experiments using the same amount of fetuin and 5mM phosphate alone failed to demonstrate retention of phosphate by the filter. Control experiments with fetuin and 5mM calcium alone did reveal retention of some calcium by the filter due to calcium binding to fetuin (20) , but the amount was substantially less than the calcium retention observed in the solution of fetuin with 5mM of both calcium and phosphate (data not shown). As seen in Table 1 , there was a further increase in the amount of calcium and phosphate retained by the filter at the 72h time point, and the molar calcium phosphate ratio at this time point was 1.60. The concentration of calcium and phosphate in the filtrate at 2h is much higher than the concentration at 72h (Table 1) , which shows that there is a very large difference in the apparent solubility between the calcium phosphate mineral phases found at these two times.
Additional experiments were carried out in order to determine whether the failure of calcium and phosphate to pass through the filter was due to the formation of a high molecular weight complex of fetuin and a calcium phosphate mineral phase similar to the fetuin-mineral complex recently discovered in the serum of rats treated with etidronate. The possible presence of the fetuin-mineral complex in solutions of fetuin and 5mM calcium and phosphate was assessed by gel filtration over Sephacryl S300HR. As seen in Figure 6 , there is a massive peak of calcium, phosphate, and fetuin in the sample at 24 hours after mixing to attain the final 5mM in calcium and phosphate, but no evidence for this peak in the sample at 12 hours after mixing.
The high molecular weight peak of fetuin, calcium, and phosphate found in the 24 hour sample is in the same elution position as the fetuin-mineral complex found in the serum of etidronate treated rats and accounts for 74% of the calcium applied to the column. Gel filtration chromatograms obtained for samples at 4 and 14 days after mixing to attain 5mM calcium and phosphate had high molecular weight peaks of fetuin, calcium, and phosphate that were identical in elution position and composition to the fetuin-mineral complex found at 24 hours (data not shown). The possible presence of the fetuin-mineral complex in solutions of fetuin and 5mM calcium and phosphate was also assessed by centrifugation for 2h at 16,000 X g. Centrifugation of the solution obtained 24h after mixing produced a translucent, compact pellet, and chemical analysis of this pellet showed that it contained calcium, phosphate, and fetuin in amounts comparable to those found in the high molecular weight peak of the Sephacryl S300 column at this time point (data not shown). In contrast, centrifugation of the solution obtained 2h after mixing did not produce a detectable pellet, and no calcium, phosphate, or fetuin could be detected at the bottom of the centrifuge tube.
The fetuin-mineral complex found in the serum of etidronate-treated rats binds MGP with high affinity, as shown by the observation that over 95% of the MGP in serum is associated with this complex (1, 16) . MGP is also found in the fetuin-mineral complex formed in serum containing 10mM added calcium and phosphate (Figure 2A) . Additional experiments were accordingly carried out to determine whether MGP binds strongly to the fetuin-mineral complex formed in vitro with purified fetuin. In the initial experiment, 100,000 cpm of 125 I-labeled rat MGP were added to a 1ml solution of fetuin and 5mM calcium and phosphate at 24h after mixing, and the solution was then filtered over a column of Sephacryl S300 as described in the Figure 6 legend. Over 95% of the MGP label eluted in the same high molecular weight position as the fetuin-mineral complex (data not shown). In contrast, when this experiment was repeated with a solution of fetuin and 5mM calcium and phosphate at 2h after mixing, there was no detectable MGP label in the elution position of the fetuin-mineral complex and all of the MGP label emerged in the 10 kDa elution position expected for MGP. These results indicate that the fetuin-mineral complex found in solutions of fetuin and 5mM calcium and phosphate at 24h after mixing has the ability to bind MGP strongly.
Although there is no centrifugation or gel filtration evidence for the presence of the fetuin-mineral complex at 2 or 12 hours after mixing to achieve 5mM in calcium and phosphate, the data in Table 1 show that there is filtration evidence for the presence of non-filterable calcium and phosphate. To see if fetuin is associated with this non-filterable calcium phosphate component, the experiment was repeated using an ultrafree CL filter with a 300 kDa molecular weight cut off, a cut off that allows passage of the 59kDa fetuin monomer through the membrane. Analysis of filtrates showed that there was again a non-filterable calcium and phosphate component in the solution containing 5mM calcium and phosphate but not in the solution containing 5mM calcium alone, and that the presence of this non-filterable calcium and phosphate component was associated with a 37% reduction in the amount of fetuin in the filtrate (data not shown). This reduction in filtrate fetuin suggests that fetuin could be bound to the nonfilterable calcium phosphate component, and that the amount of bound fetuin may be as much as 37% of the fetuin in the original solution.
mineral formation by pure fetuin at 4 mM calcium and phosphate. Experiments were carried out to determine whether a fetuin-mineral complex is also formed at 4mM calcium and phosphate. The presence of the fetuin-mineral complex at different times after mixing to achieve 4mM calcium and phosphate was initially assessed by gel filtration over Sephacryl S300HR.
These experiments showed that there is no evidence for a high molecular weight peak of fetuin, calcium, and phosphate immediately after mixing and at 4 days after mixing, and a massive high molecular weight peak of calcium, phosphate, and fetuin at 5 days after mixing (Figure 7 ).
When these experiments were repeated using filtration through a 10kDa membrane to separate free calcium from calcium associated with higher molecular weight complexes, filtrate calcium was found to remain close to initial levels for four days and then to decrease to 0.5mM between days 4 and 5 (data not shown). The solution of fetuin and 4mM calcium and phosphate was completely clear for the first 4 days and then became opalescent at day 5 and remained comparably opalescent over a 14-day period of observation. These observations show that the fetuin-mineral complex is also formed at 4mM calcium and phosphate, but the timing of its formation occurs at 4 to 5 days after mixing rather than at the 20 to 24 hours after mixing found at the 5mM calcium and phosphate conditions. The major difference between the fetuin-mineral complex formed during 3h incubation of serum containing 10mM added calcium and phosphate and the complex found in the serum of etidronate treated rats is the content of MGP, which is 40ng MGP/ml for the complex formed
DISCUSSION
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treated rats. This difference is explained by the fact that the amount of MGP that can associate with the complex in vitro is limited by the amount of MGP in 1ml of rat serum, while the amount of MGP that associates in the 9h after etidronate injection is not. In the etidronate-treated rat, the association of MGP with the fetuin-mineral complex in fact raises total serum MGP levels by over 40-fold over the first 9h after etidronate injection due to the incorporation of new MGP synthesis over this period (1) .
The present studies further support the role of fetuin as a major calcification inhibitor 2 in serum, and show that this activity of the protein may be in part be due to the formation of the fetuin-mineral complex. The conditions used here to form the complex within 3h entail raising the concentrations of calcium and phosphate in serum by 10mM each. These concentrations of calcium and phosphate are far above those that form a spontaneous mineral phase at 37ºC and pH 7.4 in the absence of proteins, and indeed the formation of a calcium phosphate precipitate occurs within seconds of mixing solutions to achieve a final 10mM
calcium and phosphate at pH 7.4 (personal observations). The fact that no precipitate formed even after incubation of serum containing 10mM calcium and phosphate for a period of 9 days at 37ºC is therefore evidence for the remarkable ability of fetuin to arrest the growth and precipitation of the mineral component of the fetuin mineral complex.
Formation of the fetuin-mineral complex with pure bovine fetuin. The present studies show that solutions of purified bovine fetuin also inhibit the growth and precipitation of a calcium phosphate mineral phase by forming complexes with mineral. The inhibition of mineral formation occurs in two stages at 5mM calcium and phosphate, and it is useful to consider each separately.
In the absence of fetuin, the first calcium phosphate mineral phase that forms at a concentration of 5mM calcium and phosphate and a pH of 7.4 is transient and soluble. This phase forms a white precipitate immediately upon mixing calcium and phosphate, and persists for about 30 minutes in apparent equilibrium with a solution calcium concentration of 3.1mM
( Figure 3) . Between 30 and 60 minutes this phase is replaced by a more stable phase with a solution calcium concentration of about 0.8mM. The initial, less stable calcium phosphate mineral phase was not noted in earlier studies at 5mM calcium and phosphate, probably because the first time points measured were 1h or later (2, 19) .
When fetuin is present, the immediate precipitation of calcium and phosphate does not occur, but there is nevertheless evidence that an initial mineral phase is formed in the presence of fetuin that has the same apparent solubility as the initial phase formed in the absence of fetuin.
This evidence includes the fact that ionic calcium levels fall to 3.1mM within 30 minutes of mixing calcium and phosphate at final concentrations of 5mM each and stay at this level for 20
hours before falling to 0.9mM at 24 hours and to 0.6mM at 30 hours. Filtration through a 10kDa membrane reveals essentially identical results, with filtrate calcium levels falling to 3.1mM within 30 minutes, staying at this level for over 16 hours, and then falling to less than 1mM calcium at 24 hours. It seems likely that fetuin forms a specific complex with this initial mineral phase, one that inhibits its growth to a size that causes visual opalescence in the solution, that inhibits its precipitation from solution, and that delays its transformation to the final, stable mineral phase from 30 minutes in the absence of fetuin to 20 hours in the presence of fetuin. The only direct evidence that fetuin does form a complex with this initial mineral phase, however, is the reduction in the passage of fetuin through a 300kDa filter that occurs in association with the presence of this calcium phosphate complex in solution. It should be noted that the putative complex formed between fetuin and the initial, soluble mineral phase is not identical to the fetuin-mineral complex seen in the serum of rats treated with etidronate, since it cannot be detected by gel filtration over a column of Sephracryl S300 or by centrifugation at 16,000 X g.
Fetuin does form a more typical fetuin-mineral complex with the final, less soluble calcium phosphate mineral phase that forms at 5mM calcium and phosphate, the phase in apparent equilibrium with a solution calcium concentration of about 0.5 mM. Since this complex binds MGP and can be detected using the same methods devised earlier for the detection of the fetuin-mineral complex in the serum of etidronate treated rats, gel filtration and sedimentation by centrifugation, it seems probable that the structure of this fetuin-mineral complex is essentially identical to the structure of the complex found in the serum of etidronate-treated rats. Solutions containing this complex of fetuin and the more stable calcium phosphate mineral phase are extraordinarily stable, and persist in solution for at least 14 days at room temperature without evidence for aggregation, growth, or precipitation.
The present studies also show that a typical fetuin-mineral complex, one essentially identical to that found in the serum of etidronate-treated rats, is formed in solutions containing purified bovine fetuin and 4mM calcium and phosphate. This complex is formed between 4 and 5 days after mixing to achieve 4mM calcium and phosphate, however, which is considerably longer than the between 20 and 24 hours found for the 5mM calcium and phosphate conditions.
The timing of fetuin-mineral complex formation at 4mM calcium and phosphate is quite reproducible and, in 10 independent experiments that were carried out over a period of 6 months, increase in calcium and phosphate needed to rapidly form the fetuin-mineral complex in serum in vitro.
1. The abbreviations used are: MGP, matrix Gla protein; fetuin, α2-HS Glycoprotein; and Gla, γ-Carboxyglutamic Acid; BRC, bone remodeling compartment; and FMC, fetuin-mineral complex.
2. "Calcification inhibitory" refers to the ability of fetuin and MGP to inhibit the formation of insoluble calcium phosphate complexes in vitro and at ectopic calcification sites in an animal.
Neither protein has been shown yet to inhibit calcification in bone, dentine, or other sites of normal mineralization. calcium and phosphate when the precipitation of mineral is inhibited by fetuin. The changes in ionic calcium levels were investigated at room temperature in solutions containing 0.2M HEPES buffer at pH 7.4 and 5mg/ml bovine fetuin. 2.5 ml aliquots of buffer were first prepared that contained 10mM phosphate (pH=7.4) or 10mM calcium. These solutions were then mixed rapidly in order to obtain a homogenous solution containing 5mM in each ionic component. The control solution contained the same 0.2M HEPES buffer, 5mg/ml fetuin, and 5mM calcium, but did not contain phosphate. Ionic calcium levels were measured at the indicated times using a calcium-specific electrode (see "Experimental Procedures"). These solutions were then mixed rapidly in order to obtain a homogenous solution containing 4mM in each ionic component. One ml aliquots were removed at t = 0, 4d, and 5d and immediately applied to a 25ml column of Sephacryl S-300 HR filtration media equilibrated at room temperature with 20mM HEPES pH 7.4, 0.15M NaCl, and 10 mMCaCl 2 . The figure shows the amount of phosphate and incorporated calcium (calculated from the 45 Ca label) in each 1ml fraction, and the absorbance at 280 nm for each fraction. Table 1 . Centrifugation evidence for fetuin-mineral complexes at 2 and 72 h after mixing to achieve 5 mM calcium and phosphate. A solution containing 0.2M HEPES buffer pH 7.4, 5mg/ml fetuin, and 5mM calcium and phosphate was prepared as described in the Figure 5 legend. 0.5 ml aliquots were removed at the indicated times and immediately filtered through a 10 kDa membrane using aYM-10 filtration unit. 
